Govt to set up 10 labs for hepatitis surveillance

Image
Press Trust of India New Delhi
Last Updated : Jul 28 2014 | 5:04 PM IST
Government will set up ten regional laboratories through the National Communicable Disease Centre (NCDC) for the surveillance of viral hepatitis, which kills more people than HIV/AIDS, malaria and dengue combined together in India.
"The aim of these laboratories will be to find the burden of viral hepatitis in India by 2017 and to provide lab support for investigating outbreaks," Lov Verma, Secretary of Union Health Ministry said today at a roundtable consultation organised by Institute of Liver and Biliary Sciences (ILBS) in collaboration with WHO Country Office for India on the occasion of World Hepatitis Day.
He also stressed on focusing on the preventive aspects rather than treatment of viral Hepatitis given the limited health resources in India.
Mass awareness, education and setting up universal guidelines for immunization are needed to fight the disease which kills three lakh people across the country every year.
Standardisation of blood bank practices and introduction of nucleic acid testing (NAT) is important for preventing blood transfusions related to viral hepatitis, Verma said.
There are five main hepatitis viruses, types A, B, C, D and E of which B and C is most fatal as it can lead to liver cirrhosis and cancer. Hepatitis B and C are both blood borne and can be transmitted from man to man.
"Hepatitis B is responsible for 1.4 million deaths every year (compared to 1.5 million deaths from HIV/AIDS and 1.2 million from each of malaria and TB)," said Shiv Sarin, Director of ILBS as he called for collective efforts in reducing the burden of the disease.
"India has over 40 million hepatitis B infected patients (second only to China) and constitutes about 15 per cent of the entire pool of hepatitis B in the world. Tribal areas in India have high prevalence of hepatitis B. Every year, nearly 600,000 patients die from HBV infection in the Indian continent. Outbreaks of acute and fulminant hepatitis B still occur mainly due to inadequately sterilized needles and syringes," explained Sarin.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 28 2014 | 5:04 PM IST

Next Story